219 related articles for article (PubMed ID: 7498555)
1. Novel guanylyl cyclase inhibitor, ODQ reveals role of nitric oxide, but not of cyclic GMP in endothelin-1 secretion.
Brunner F; Stessel H; Kukovetz WR
FEBS Lett; 1995 Dec; 376(3):262-6. PubMed ID: 7498555
[TBL] [Abstract][Full Text] [Related]
2. Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells.
Mitsutomi N; Akashi C; Odagiri J; Matsumura Y
Eur J Pharmacol; 1999 Jan; 364(1):65-73. PubMed ID: 9920186
[TBL] [Abstract][Full Text] [Related]
3. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
4. Novel guanylyl cyclase inhibitor potently inhibits cyclic GMP accumulation in endothelial cells and relaxation of bovine pulmonary artery.
Brunner F; Schmidt K; Nielsen EB; Mayer B
J Pharmacol Exp Ther; 1996 Apr; 277(1):48-53. PubMed ID: 8613957
[TBL] [Abstract][Full Text] [Related]
5. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele E; Jin Y; Varnier G; Raiteri M
Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
[TBL] [Abstract][Full Text] [Related]
6. Tonic inhibitory action by nitric oxide on spontaneous mechanical activity in rat proximal colon: involvement of cyclic GMP and apamin-sensitive K+ channels.
Mulè F; D'Angelo S; Serio R
Br J Pharmacol; 1999 May; 127(2):514-20. PubMed ID: 10385253
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two soluble guanylyl cyclase inhibitors, methylene blue and ODQ, on sodium nitroprusside-induced relaxation in guinea-pig trachea.
Hwang TL; Wu CC; Teng CM
Br J Pharmacol; 1998 Nov; 125(6):1158-63. PubMed ID: 9863642
[TBL] [Abstract][Full Text] [Related]
8. The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.
Onoue H; Katusic ZS
Brain Res; 1998 Feb; 785(1):107-13. PubMed ID: 9526059
[TBL] [Abstract][Full Text] [Related]
9. Involvement of NO/cGMP pathway in toluene-induced locomotor hyperactivity in female rats.
Chan MH; Chien TH; Lee PY; Chen HH
Psychopharmacology (Berl); 2004 Nov; 176(3-4):435-9. PubMed ID: 15118807
[TBL] [Abstract][Full Text] [Related]
10. The nitric oxide-cyclic GMP pathway and synaptic plasticity in the rat superior cervical ganglion.
Southam E; Charles SL; Garthwaite J
Br J Pharmacol; 1996 Oct; 119(3):527-32. PubMed ID: 8894173
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
12. Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.
Wegener JW; Closs EI; Förstermann U; Nawrath H
Br J Pharmacol; 1999 Jun; 127(3):693-700. PubMed ID: 10401560
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase.
Boulton CL; Southam E; Garthwaite J
Neuroscience; 1995 Dec; 69(3):699-703. PubMed ID: 8596640
[TBL] [Abstract][Full Text] [Related]
14. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide induces resensitization of P2Y nucleotide receptors in cultured rat mesangial cells.
Liu R; Gutiérrez AM; Ring A; Persson AEG
J Am Soc Nephrol; 2002 Feb; 13(2):313-321. PubMed ID: 11805158
[TBL] [Abstract][Full Text] [Related]
16. 1H-[1,2,4] oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) inhibits cyclic GMP-PKG pathway-independent nonadrenergic, noncholinergic relaxation in longitudinal muscle of the rectum of Wistar-ST rats.
Nakagawa M; Takeuchi T; Niioka S; Yamaji M; Okishio Y; Nishio H; Hata F
Jpn J Pharmacol; 2000 Feb; 82(2):164-7. PubMed ID: 10877536
[TBL] [Abstract][Full Text] [Related]
17. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
[TBL] [Abstract][Full Text] [Related]
18. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase.
Moro MA; Russel RJ; Cellek S; Lizasoain I; Su Y; Darley-Usmar VM; Radomski MW; Moncada S
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1480-5. PubMed ID: 8643658
[TBL] [Abstract][Full Text] [Related]
19. Intracerebroventricular administration of nitric oxide-sensitive guanylyl cyclase inhibitors induces catalepsy in mice.
Echeverry MB; Salgado ML; Ferreira FR; da-Silva CA; Del Bel EA
Psychopharmacology (Berl); 2007 Oct; 194(2):271-8. PubMed ID: 17593355
[TBL] [Abstract][Full Text] [Related]
20. Effects of a novel inhibitor of guanylyl cyclase on dilator responses of mouse cerebral arterioles.
Sobey CG; Faraci FM
Stroke; 1997 Apr; 28(4):837-42; discussion 842-3. PubMed ID: 9099205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
